|

Innovation and valuation drive the rebound in healthcare

Despite healthcare facing severe headwinds in recent quarters, Gareth Powell and James Douglas of the Polar Capital Global Healthcare Team explain that valuations are now at historic lows and many of the underlying concerns, including tariff threats and leadership appointments, appear more than priced in. They discuss how key long-term drivers such as innovation, utilisation growth, and rising emerging market demand remain intact.